Clinical Trial Update: Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease [NA]

View source ↗

Summary

A clinical trial evaluating the MEX-CD1 low-volume continuous venovenous haemodialysis device for copper extraction in Wilson disease has been terminated; the u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Snippet

Sponsor: Mexbrain | Conditions: Hepatolenticular Degeneration; Wilson | NA | Status: TERMINATED